Case Study – Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)
Discover how we managed cell isolation and counts among other routine and speciality tests for a large Relapse Refractory Multiple Myeloma study over 11,000 samples managed.
Tests including FCM, PBMC isolation and count, FISH
Case Study – Phase 2 Relapse Refractory Multiple Myeloma (RRMM)
Reach out to our experts and discover how we can help you advance your clinical trial